Landon Capital

Landon capital

Capital Market News, Capital Markets Now

ARBKL

5.3 USD

+ 201.14%
MSOX

7.89 USD

+ 106.54%
RVSNW

0.18 USD

+ 100.00%
YCBD

1.21 USD

+ 91.76%
MAPSW

0.0197 USD

+ 82.41%
MSPRZ

0.04 USD

+ 63.27%
BIAFW

0.37 USD

+ 59.07%
THH

15.52 USD

+ 57.72%
NCI

1.92 USD

+ 54.84%
MSOS

5.81 USD

+ 54.52%
BNZIW

0.0247 USD

+ 54.38%
CNBS

34.76 USD

+ 54.30%
CGC

1.74 USD

+ 53.98%
WEED

24.54 USD

+ 50.83%
MOBXW

0.12 USD

+ 50.00%
RYM

23.8 USD

+ 47.73%
AERTW

0.038 USD

+ 45.04%
TLRY

12.15 USD

+ 44.13%
MJ

38.25 USD

+ 42.62%
SBFMW

0.24 USD

+ 41.18%

Top Gainer

Latest News

Tell me something good, Kyverna Therapeutics announce positive SPS trial data Kyverna Therapeutics (NASDAQ: KYTX) stock surged 14% Monday after the company announced positive topline data from its registrational Phase 2 trial of mivocabtagene autoleucel (miv-cel) in stiff person syndrome (SPS). The clinical-stage biopharmaceutical company reported that miv-cel achieved statistically significant clinical benefits across all primary and secondary endpoints in …

Cencora to acquire majority stake in OneOncology for $3.6 billion Cencora Inc. (COR) announced it entered a definitive agreement to acquire the majority of outstanding equity interests it does not currently own in OneOncology from TPG for approximately $3.6 billion. The transaction values OneOncology at $7.4 billion enterprise value with an equity value of approximately $6 billion. Cencora will also …